Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Savara Inc (SVRA)
Savara Inc (SVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Savara Inc 1717 LANGHORE NEWTOWN ROAD SUITE 300 AUSTIN TX 19047 USA

www.savarapharma.com P: 512-614-1848 F: 855-298-2020

Description:

Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States.

Key Statistics

Overview:

Market Capitalization, $K 544,071
Enterprise Value, $K 518,051
Shares Outstanding, K 135,341
Annual Sales, $ 0 K
Annual Net Income, $ -38,150 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -16,600 K
EBIT, $ -53,190 K
EBITDA, $ -52,610 K
60-Month Beta 0.78
% of Insider Shareholders 4.58%
% of Institutional Shareholders 97.28%
Float, K 129,142
% Float 95.42%
Short Volume Ratio 0.16

Growth:

1-Year Return 158.39%
3-Year Return 232.23%
5-Year Return -45.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 85.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 11/09/23
Next Earnings Date N/A
Earnings Per Share ttm -0.31
EPS Growth vs. Prev Qtr -42.86%
EPS Growth vs. Prev Year -42.86%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-70 on 04/28/17

SVRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.42%
Return-on-Assets % -34.25%
Profit Margin % 0.00%
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.60
Book Value/Share 1.08
Interest Coverage -422.89
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar